Dr. Reddy's launches Sorafenib Tablets in US market
Capital MarketDr. Reddy's Laboratories announced the launch of Dr. Reddy's Sorafenib Tablets, USP, 200 mg, a therapeutic generic equivalent of Nexavar (sorafenib) Tablets in the U.S. market following the approval by the U.S. Food and Drug Administration (USFDA).
Dr. Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
